Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

@article{Greengrass2009EvaluationOT,
  title={Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.},
  author={Vicki L Greengrass and Megan M Plate and Pauline M Steele and Justin T Denholm and Catherine Louise Cherry and Lisa M. Morris and Anna C. Hearps and Suzanne M. Crowe},
  journal={Journal of clinical microbiology},
  year={2009},
  volume={47 9},
  pages={3011-3}
}
We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.